Sort by
Refine Your Search
-
are available from 1 July 2025 to 30 June 2026 in the first instance. Based in the interdisciplinary Living Systems Institute, the successful applicants will join a world-leading programme of investigations
-
Support Program, 2 talents with the National Outstanding Youth Fund as well as more than 30 winners of various national, provincial and ministerial talent projects. With advanced technology and equipment
-
range of methodologies including developmental and cell biology, cancer biology, next generation sequencing and computational modelling. The Hill lab encourages creative and independent thinking and
-
mammalian animal models with extraordinary tissue regenerative capacity. 5. Investigating human genetic mutations and underlying molecular mechanisms in rare heart diseases that may result in preservation
-
Cancer Clinical Research Facility (Cancer CRF, jointly developed with University College Hospital), and the CR-UK/UCL Clinical Trials Centre (CTC). TRACERx is a UK-wide lung cancer evolution programme
-
patients. YOUR ROLE IN OUR FUTURE Postdoctoral Fellow (Bioinformatics & Computational Biology) - Mark Dawson Laboratory Applications are invited to join an exciting multi-discliplinary research program
-
mechanisms of normal hematopoietic and leukemic cells and apply computational biology models to address specific questions in orthogonal multiomics approaches to analyses of signaling pathways in disease and
-
A full-time postdoctoral fellow position is available in Professor Wenyi Wang's lab at the Department of Bioinformatics and Computational Biology, the University of Texas MD Anderson Cancer Center
-
fusion proteins. We aim to understand the mechanisms by which oncogenic fusion proteins drive leukemia, in order to disrupt their activity for therapeutic purposes. Oncogenic fusion proteins can promote
-
College Hospital), and the CR-UK/UCL Clinical Trials Centre (CTC). TRACERx is a UK-wide lung cancer evolution programme which started in 2014 and has to date recruited over 820 patients. It is the first